Bioequivalence Study in Healthy Subjects by Using of Chlorpromazine HCl 100mg Tablets
Status:
Completed
Trial end date:
2019-02-12
Target enrollment:
Participant gender:
Summary
This clinical study is an open label, randomized, fasting condition, single-dose, two-period
crossover study to compare the bioequivalence of Chlorpromazine HCl 100mg Tablets after oral
administration in healthy subjects.